Should Cerebral Care prioritize expanding its medication management services or investing in more comprehensive therapy offerings?

Introduction

The trade-off question at hand is whether Cerebral Care should prioritize expanding its medication management services or invest in more comprehensive therapy offerings. This scenario involves balancing the growth of two core service areas within a mental health platform. I'll approach this analysis by examining the current product landscape, evaluating potential impacts, and designing experiments to inform our decision-making process.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm thinking Cerebral Care is facing increasing competition in the teletherapy space. Could you share more about our current market position and main competitors?

Why it matters: Helps assess the urgency of expanding different service areas Expected answer: We're a top 5 player but losing market share to newer entrants Impact on approach: Would influence whether we prioritize differentiation or market expansion

• Business Context: Based on our revenue model, I assume medication management is currently our primary revenue driver. Is this correct, and how does the profitability compare between medication management and therapy services?

Why it matters: Informs the financial implications of our trade-off decision Expected answer: Medication management has higher margins but therapy is growing faster Impact on approach: Would affect how we balance short-term revenue vs long-term growth

• User Impact: I'm curious about our user segments. What percentage of our users currently use both medication management and therapy services?

Why it matters: Helps understand potential for cross-selling and user journey optimization Expected answer: About 30% use both services, with room for growth Impact on approach: Would influence how we design experiments to test cross-service adoption

• Technical: Regarding our platform capabilities, how scalable is our current infrastructure for handling increased demand in either medication management or therapy services?

Why it matters: Assesses technical feasibility of rapid expansion in either direction Expected answer: More headroom for scaling therapy services than medication management Impact on approach: Could impact the timeline and resource allocation for expansion efforts

• Resource: In terms of our current team composition, do we have more capacity to expand our network of prescribing physicians or therapists?

Why it matters: Determines our ability to execute on either expansion strategy Expected answer: Easier to onboard therapists due to less stringent regulatory requirements Impact on approach: Might favor therapy expansion if medication management faces resource constraints